Fianna Fáil - 🇮🇪Ireland is now in 1st position in EU for booster uptake for those aged +18 >2.2m doses (boosters + 3rd doses) administered to date >1m booster doses were administered
![Pokémon TCG: Scarlet & Violet-Obsidian Flames 3 Booster Packs & Greavard Promo Card | Pokémon Center Official Site Pokémon TCG: Scarlet & Violet-Obsidian Flames 3 Booster Packs & Greavard Promo Card | Pokémon Center Official Site](https://www.pokemoncenter.com/images/DAMRoot/High/10000/P8979_699-85379_02.jpg)
Pokémon TCG: Scarlet & Violet-Obsidian Flames 3 Booster Packs & Greavard Promo Card | Pokémon Center Official Site
![Seniors 70 and older, front-line health workers, people who got 2 AZ doses can be offered boosters, NACI says | CBC News Seniors 70 and older, front-line health workers, people who got 2 AZ doses can be offered boosters, NACI says | CBC News](https://i.cbc.ca/1.6229531.1635464497!/fileImage/httpImage/covid-vaccinations-toronto.jpg)
Seniors 70 and older, front-line health workers, people who got 2 AZ doses can be offered boosters, NACI says | CBC News
![Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study - The Lancet Infectious Diseases Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/d5e75a06-cd51-448a-b6b1-e061dadda723/gr1.jpg)
Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study - The Lancet Infectious Diseases
![Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet](https://www.thelancet.com/cms/asset/43c19cc3-58f4-41c4-8c50-86f1f443c0fb/gr1.jpg)